A large proportion of patients with cancer suffer from breakthrough cancer pain (BTcP). Several unmet clinical needs concerning BTcP treatment, such as optimal opioid dosages, are being investigated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback